Literature DB >> 24160932

Acute liver failure.

Tony Whitehouse1, Julia Wendon.   

Abstract

Untreated acute liver failure (ALF) has a poor outcome and so rapid diagnosis and management is vital if the patient is to survive. ALF has such profound and widespread physiological consequences that whenever possible, patients with ALF should be managed in an intensive care unit. Management is to support the physiology and treat the underlying cause. Advice should be sought from a centre capable of performing liver transplantation. Should recovery seem unlikely, liver transplantation is a viable treatment option in some cases.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute; Diagnosis; Liver failure; Management; Physiopathology

Mesh:

Year:  2013        PMID: 24160932     DOI: 10.1016/j.bpg.2013.08.010

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  8 in total

Review 1.  Liver Stem Cells: Experimental Findings and Implications for Human Liver Disease.

Authors:  George K Michalopoulos; Zahida Khan
Journal:  Gastroenterology       Date:  2015-08-14       Impact factor: 22.682

2.  Hepatoprotective effect of nitric oxide in experimental model of acute hepatic failure.

Authors:  Marek Saracyn; Marek Brytan; Robert Zdanowski; Tomasz Ząbkowski; Przemysław Dyrla; Janusz Patera; Stanisław Wojtuń; Wojciech Kozłowski; Zofia Wańkowicz
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

3.  Deregulation of Regulatory T Cells in Acute-on-Chronic Liver Failure: A Rat Model.

Authors:  Shunlan Ni; Shanshan Li; Naibin Yang; Xinyue Tang; Shengguo Zhang; Danping Hu; Mingqin Lu
Journal:  Mediators Inflamm       Date:  2017-01-15       Impact factor: 4.711

4.  Immune reconstitution inflammatory syndrome as a cause of autoimmune hepatitis and acute liver failure.

Authors:  Edison Moraes Rodrigues; Rogério Fernandes; Ruth Susin; Bárbara Fior
Journal:  Rev Bras Ter Intensiva       Date:  2017 Jul-Sep

5.  Complement System as a Target for Therapies to Control Liver Regeneration/Damage in Acute Liver Failure Induced by Viral Hepatitis.

Authors:  Juliana Gil Melgaço; Carlos Eduardo Veloso; Lúcio Filgueiras Pacheco-Moreira; Claudia Lamarca Vitral; Marcelo Alves Pinto
Journal:  J Immunol Res       Date:  2018-10-08       Impact factor: 4.818

6.  In vivo siRNA delivery of Keap1 modulates death and survival signaling pathways and attenuates concanavalin-A-induced acute liver injury in mice.

Authors:  Águeda González-Rodríguez; Bjorn Reibert; Thomas Amann; Rainier Constien; Cristina M Rondinone; Ángela M Valverde
Journal:  Dis Model Mech       Date:  2014-07-04       Impact factor: 5.758

7.  Artificial liver support in pigs with acetaminophen-induced acute liver failure.

Authors:  Guo-Lin He; Lei Feng; Lei Cai; Chen-Jie Zhou; Yuan Cheng; Ze-Sheng Jiang; Ming-Xin Pan; Yi Gao
Journal:  World J Gastroenterol       Date:  2017-05-14       Impact factor: 5.742

8.  Hepatoprotective Effects of Kaempferol-3-O-α-l-Arabinopyranosyl-7-O-α-l-Rhamnopyranoside on d-Galactosamine and Lipopolysaccharide Caused Hepatic Failure in Mice.

Authors:  Lin Dong; Lei Yin; Hongfeng Quan; Yuankui Chu; Jincai Lu
Journal:  Molecules       Date:  2017-10-18       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.